OAE for pg exam notes in simplified manner from standard ent textbook

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
I now have comprehensive information from multiple standard ENT textbooks. Let me compile the complete, PG exam-focused notes.

Otoacoustic Emissions (OAE) - PG Exam Notes

Sources: Cummings Otolaryngology, KJ Lee's Essential Otolaryngology, Shambaugh Surgery of the Ear, Scott-Brown's Otorhinolaryngology

1. Definition

  • OAEs are low-intensity sounds generated by the cochlear outer hair cells (OHCs) that travel backward through the middle ear into the external ear canal, where they are recorded by a sensitive microphone.
  • They are an epiphenomenon - a byproduct of active OHC processing, NOT a process of hearing itself.
  • First described by David Kemp (1978) - hence sometimes called "Kemp echoes" or "cochlear echoes."

2. Mechanism / Pathway of Energy

OHC motility → Basilar membrane → Cochlear fluids → Oval window → Ossicles → Tympanic membrane (acts as loudspeaker) → External ear canal
  • The active motility (electromotility) of OHCs amplifies displacement of the cochlear partition, producing these acoustic by-products.

3. Prerequisites for Recording OAE

For OAEs to be recorded, the following must be intact:
  1. Functioning OHCs (cochlear integrity)
  2. Normal middle ear function (both for sound to reach the cochlea AND for OAE energy to travel back out)
  3. Patent external ear canal (no obstruction/wax)
  4. Quiet environment (not necessarily sound-treated, but quiet)
  5. Still and calm patient (no behavioral response needed)
Key Point: OAEs are absent in conductive hearing loss not because OHCs are damaged, but because the middle ear blocks the outgoing emission.

4. Classification of OAEs

A. Spontaneous OAEs (SOAEs)

  • Occur without any external stimulus
  • Present in 35-60% of normally hearing individuals
  • Absence is non-diagnostic (absent even in many normal ears)
  • Not reliably correlated with tinnitus
  • Rarely used clinically

B. Evoked OAEs (EOAEs) - Clinically Important

i. Transient Evoked OAEs (TEOAEs)

FeatureDetail
StimulusBroadband click or brief tone burst at ~80-85 dB SPL
Frequency range0.4 - 6 kHz (practically up to 4 kHz in clinical use)
Latency5-20 ms (response begins ~4 ms, continues ~10 ms after stimulus)
ResponseLow-intensity (~30 dB lower than stimulus)
InterpretationPresent/Absent by octave band
Threshold indicatorPresent TEOAE = cochlear hearing no worse than 30-40 dB HL
AnalysisReproducibility % - if >50% reproducible AND signal exceeds noise floor, OAE is "present"

ii. Distortion Product OAEs (DPOAEs)

FeatureDetail
StimulusTwo simultaneous pure tones (f1 and f2)
Key formulaMost prominent DP at 2f1 - f2 (cubic difference tone)
f1/f2 ratioBest at f2/f1 = 1.2
Stimulus levelsf1 = 65 dB SPL, f2 = 55 dB SPL (or both 55-65 dB SPL)
Frequency range~1000 - 6000 Hz (broader than TEOAE)
Amplitude~60 dB lower than primary tones
AdvantageFrequency-specific; can sometimes be recorded even in moderate-to-severe hearing loss
OutputDP-gram (amplitude vs. frequency of f2)

iii. Stimulus Frequency OAEs (SFOAEs)

  • Elicited by a continuous pure tone stimulus
  • Rarely used clinically

5. TEOAE vs DPOAE - Quick Comparison (PG Favorite)

FeatureTEOAEDPOAE
StimulusClick / tone burst2 simultaneous pure tones (f1 + f2)
Key frequency2f1 - f2Broadband (same as click)
Frequency specificityLess specificMore specific
Threshold sensitivityAbsent if >30-40 dB SNHLCan persist in moderate SNHL
Clinical useNewborn screening (preferred)Ototoxicity monitoring, noise-induced HL
Test time~5-10 min per ear~5-10 min per ear
EnvironmentQuiet (not sound-treated)Quiet (not sound-treated)

6. What OAE Tests - and What It Does NOT Test

OAE TESTS:
  • Outer hair cell (OHC) function only
  • Cochlear integrity at specific frequency regions
  • Presence/absence of >30-40 dB cochlear hearing loss
OAE DOES NOT TEST:
  • Inner hair cells (IHC)
  • Auditory nerve / retrocochlear pathway
  • Central auditory processing
  • Hearing thresholds precisely
Critical PG Point: Retrocochlear lesions (e.g., acoustic neuroma) = OAE normal, ABR abnormal

7. Interpretation Pattern for PG Exams

FindingInterpretation
OAE present + ABR normalNormal hearing
OAE absent + normal middle earCochlear (OHC) damage, >30-40 dB SNHL
OAE absent + abnormal tympanogramConductive hearing loss (middle ear problem)
OAE present + ABR absentAuditory Neuropathy Spectrum Disorder (ANSD)
OAE present + behavioral hearing lossSuspect non-organic/functional hearing loss

8. Auditory Neuropathy Spectrum Disorder (ANSD) - High Yield

  • Hallmark: Normal OAEs (intact OHCs) + absent/grossly abnormal ABR
  • Cochlear microphonic (CM) may be present (wave I of ABR)
  • Site of lesion: IHCs, auditory nerve, or synaptic junction
  • OAE may disappear over time even in ANSD
  • Management: Cochlear implant often beneficial

9. Clinical Applications of OAE

ApplicationType Used
Newborn hearing screening (NHS)TEOAE (preferred) or DPOAE
Ototoxicity monitoring (cisplatin, aminoglycosides)DPOAE (frequency specific)
Noise-induced hearing loss monitoringDPOAE
Diagnosis of ANSDTEOAE or DPOAE
Differential: cochlear vs retrocochlearOAE (present in retrocochlear)
Intraoperative monitoring (vestibular schwannoma)Occasionally OAE
Non-organic/malingering detectionOAE (objective test)
Tinnitus evaluationLimited role (some correlation with SOAEs)

10. Newborn Hearing Screening - OAE Role

  • Universal Neonatal Hearing Screening (UNHS) uses automated OAE (AOAE) as the first-line tool
  • Two protocols:
    • 1-step: OAE alone or AABR alone
    • 2-step: OAE first → AABR for those who fail OAE ("refer")
  • OAE cannot detect ANSD → high-risk newborns (NICU, hyperbilirubinemia, ototoxic drugs) should also have AABR
  • Refer criterion: If OAE absent in well-baby nursery, rescreen within 1 month; if still refers, full audiologic assessment
PG Note: If newborn screened with OAE only and has ANSD, they will PASS OAE but have hearing dysfunction - this is why AABR is added in high-risk groups.

11. Factors Affecting OAE Recording

FactorEffect
Middle ear effusion / OMEAbsent OAE (most common cause in children)
Cerumen/debris in canalAbsent/reduced OAE
Probe fitCritical - poor seal gives absent/unreliable results
Background noiseRaises noise floor, may mask OAE
Cochlear SNHL >30-40 dBAbsent OAE
SedationNOT required (patient just needs to be still)
Crying/movementIncreases noise, reduces reliability

12. Advantages of OAE Over ABR

  1. Faster - 5-10 minutes per ear vs. 30-60 minutes for ABR
  2. No sedation needed in most cases
  3. Simpler setup - probe placement only, no electrodes
  4. Objective - no behavioral response required
  5. Specific to OHC/cochlear function

13. Limitations of OAE

  1. Does NOT assess auditory nerve or central pathways
  2. Affected by middle ear pathology (false negatives)
  3. Cannot give precise hearing thresholds
  4. Will miss ANSD if used alone for screening
  5. High refer rate in first 24-48 hours of life (fluid/debris in canal)

14. Quick Memory Tables

OAE Type - Stimulus - Frequency (3-line memory trick)

  • SOAE = No stimulus, narrowband peaks, present in ~50% normal ears
  • TEOAE = Click → broad response, 0.4-6 kHz, latency 5-20 ms
  • DPOAE = Two tones (f1, f2) → 2f1-f2, frequency specific, 1-6 kHz

Key Numbers to Remember

  • OAE absent when SNHL > 30-40 dB
  • SOAE present in 35-60% of normal ears
  • TEOAE latency: 5-20 ms
  • DPOAE formula: 2f1 - f2
  • DPOAE f2/f1 ratio: 1.2
  • DPOAE amplitude: ~60 dB lower than primary tones
  • Test time: 5-10 min per ear
  • TEOAE stimulus level: ~80-85 dB SPL

Sources: Cummings Otolaryngology Head & Neck Surgery (5th ed.) | KJ Lee's Essential Otolaryngology (11th ed.) | Shambaugh Surgery of the Ear (6th ed.) | Scott-Brown's Otorhinolaryngology Vol. 1 & 2
This is a shared conversation. Sign in to Orris to start your own chat.